PANews, November 22 - According to a press release, Anixa Biosciences, Inc. (NASDAQ: ANIX), a publicly traded company in the United States, announced that its board of directors has approved the purchase of Bitcoin as a treasury reserve asset, aiming to diversify the company’s assets while allowing Anixa to benefit from the potential long-term value of digital assets.
It is reported that Anixa is a clinical-stage biotechnology company focused on cancer treatment and prevention.
